StockMarketWire.com - Numis today reaffirms its buy investment rating on Circassia Pharmaceuticals Plc [LON:CIR] and cut its price target to 140p (from 180p).

Story provided by StockMarketWire.com

Broker Forecasts data provided by www.sharesmagazine.co.uk